C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy.
Sliwa
Karen
K
Department of Cardiology, Chris-Hani Baragwanath Hospital, University of the Witwatersrand, P.O. Bertsham, 2013, Johannesburg, South Africa. hahnle@netactive.co.za
Woodiwiss
Angela
A
Libhaber
Elena
E
Zhanje
Fitzgerald
F
Libhaber
Carlos
C
Motara
Riaz
R
Essop
Rafique
R
D002097:C-Reactive Protein / Q000032:analysis*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy*; D006801:Humans; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D013599:Systole / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016277:Ventricular Function, Left / Q000187:drug effects; D019014:fas Receptor / Q000097:blood
D014409:Tumor Necrosis Factor-alpha; D014665:Vasodilator Agents; D019014:fas Receptor; D002097:C-Reactive Protein; D010431:Pentoxifylline